IRadimed Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	17.19	12.83	9.33	1.37	9.63	6.3	0.5	7.21	7.53	2.05	Upgrade
Depreciation & Amortization	0.77	0.67	1.41	1.34	1.24	1.11	1.31	0.96	0.81	0.15	Upgrade
Share-Based Compensation	2.19	1.39	1.46	3.96	1.85	1.76	2.45	1.24	-0.51	0.56	Upgrade
Other Operating Activities	-6.68	-4.85	-0.93	-0.85	-2.5	-1.8	-0.85	-0	-0.18	-0.17	Upgrade
Operating Cash Flow	13.47	10.04	11.26	5.82	10.23	7.38	3.42	9.41	7.65	2.59	Upgrade
Operating Cash Flow Growth	34.08%	-10.80%	93.52%	-43.15%	38.73%	115.93%	-63.68%	22.97%	195.83%	75.37%	Upgrade
Capital Expenditures	-8.01	-1.87	-0.74	-0.64	-0.49	-0.26	-0.82	-1.52	-0.31	-0.61	Upgrade
Change in Investments	0	0.5	1.39	0.88	3.69	1.78	-0.2	-0.42	0.25	-7.7	Upgrade
Investing Cash Flow	-8.01	-1.37	0.65	0.25	3.2	1.52	-1.02	-1.94	-0.06	-8.3	Upgrade
Dividends Paid	-13.22	-12.56	0	0	0	0	0	0	0	0	Upgrade
Share Issuance / Repurchase	0.18	0.15	0.62	1.73	2.49	1.24	-1.74	-9.72	0.6	12.55	Upgrade
Debt Issued / Paid	0	0	0	0	0	0	0	0	0	-0.01	Upgrade
Other Financing Activities	-0.61	-0.29	-0.6	-1.21	-0.47	-0.31	-0.16	0.6	1.73	0.17	Upgrade
Financing Cash Flow	-13.66	-12.71	0.02	0.52	2.02	0.93	-1.9	-9.12	2.33	12.71	Upgrade
Net Cash Flow	-8.2	-4.04	11.93	6.59	15.45	9.82	0.49	-1.65	9.91	6.99	Upgrade
Free Cash Flow	5.46	8.17	10.52	5.18	9.75	7.11	2.59	7.88	7.33	1.98	Upgrade
Free Cash Flow Growth	-33.18%	-22.33%	102.99%	-46.85%	37.06%	174.45%	-67.13%	7.47%	270.54%	54.33%	Upgrade
Free Cash Flow Margin	8.32%	15.32%	25.15%	16.33%	25.31%	23.36%	11.23%	24.25%	23.22%	12.65%	Upgrade
Free Cash Flow Per Share	0.43	0.65	0.85	0.42	0.86	0.66	0.24	0.73	0.67	0.23	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).